“…The 22 eligible studies captured eight TCF7L2 SNPs, and included 5,573 cases and 13,266 controls. There were 18 studies about rs7903146, 10 about rs12255372, 5 about rs7901695, 3 about rs290487, 2 about rs11196205, 2 17 Asian Korea 32/64.7 Allelic discrimination assay IWCGDM de Melo, (2015) 26 Hispanic/Latino Brazil 32/24 SNP Genotyping Assay ADA Freathy, (2010) 12 Mixed Australia and UK NA Illumina Golden Gate platform OGTT Kan, (2014) 15 Asian China 30.7/30.9 Allelic discrimination assay OGTT Huerta-Chagoya, (2015) 25 20 Caucasian Sweden NA TaqMan allelic discrimination assay OGTT Reyes-L opez, (2014) 21 Mexican Mexico 29/31 PCR ADA RIZK, (2011) 16 Caucasian Qatar NA TaqMan allelic discrimination assay NA Shaat, (2007) 14 Caucasian Scandinavia 32.3/30.5 TaqMan allelic discrimination assay OGTT Shi, (2014) 28 Asian China 30/29 AS-PCR OGTT Stuebe, (2014) 31 African-American USA 24.1 (total) Sequenom iPLEX platform OGTT Thomas, (2014) 24 Asian India NA NA NA Vcelak, (2012) 18 Caucasian Czech Republic 32.8/29.9 TaqMan allelic discrimination assay WHO Wang, (2013) 39 Asian China NA PCR-LDR OGTT Watanabe, (2007) 30 Mexican-American USA 35.0/33.4 TaqMan allelic discrimination assay OGTT Zhang, (2015) 23 Asian Tables 1 and 2.…”